Key facts
- This page summarizes Mark S. Black's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2023, 18:23.
Mark S. Black - 29 May 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Reporting relationship
- Director
- Issuer ticker
- AXDX
- Reported as of
- 29 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2023, 18:23:52 UTC
- Prior SEC filing
- 01 Jun 2023
- Next SEC filing
- 21 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Patience, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark S. Black filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 01 Jun 2023.
Change
- Previous filing in this sequence was filed on 01 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXDX
transaction
Derivative
Employee Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +78,947
- Change %
- Price
- $0.000000
- Shares after
- 78,947
- Date
- 29 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 78,947
- Exercise price
- Footnotes
- F1, F2, F3, F4
AXDX
transaction
Derivative
Employee Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +236,842
- Change %
- Price
- $0.000000
- Shares after
- 236,842
- Date
- 29 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 236,842
- Exercise price
- Footnotes
- F1, F3, F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Footnote F2
On May 29, 2023, the reporting person was granted RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served.
Footnote F3
Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the restricted stock units to such time that is within 30 days following his departure from the issuer's board of directors.
Footnote F4
Not applicable.
Footnote F5
On May 29, 2023, the reporting person was granted RSUs which vest each year for 5 years, with the first installment vesting on May 29, 2024.